Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4

International Journal of Cancer

Volumn 86, Issue 6, 2000, Pages 835-841

  Landry, Claire ^a   Brasseur, Francis ^a   Spagnoli, Giulio C ^b   Marbaix, Etienne ^c   Boon, Thierry ^a,d   Coulie, Pierre ^d   Godelaine, Danièle ^a,d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ARTICLE; BREAST CARCINOMA; CANCER IMMUNOTHERAPY; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MELANOMA; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; COS CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034659682     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N     Document Type: Article

References (25)

1. CARNEY, D.N., BUNN, P.A., GAZDAR, A.F., PAGAN, J.A. and MINNA, J.D., Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc. Nat. Acad. Sci. (Wash.), 78, 3185-3189 (1981).
2. CELIS, E., TSAI, V., CRIMI, C., DEMARS, R., WENTWORTH, P.A., CHESNUT, R.W., GREY, H.M., SETTE, A. and SERRA, H.M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Nat. Acad. Sci. (Wash.), 91, 2105-2109 (1994).
3. DAVIS, L.G., DIBNER, M.D. and BATTEY, J.F., Guanidine isothiocyanate preparation of total RNA. In: Basic methods in molecular biology, pp. 130-135, Elsevier, New York (1986).
4. DE PLAEN, E. and 14 OTHERS, Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
5. DE PLAEN, E., NAERHUYZEN, B., DE SMET, C., SZIKORA, J.-P. and BOON, T., Alternative promoters of gene MAGE4a. Genomics, 40, 305-313 (1997).
6. FISCHER, C., GUDAT, F., STULZ, P., NOPPEN, C., SCHAEFER, C., ZAJAC, P., TRUTMANN, M., KOCHER, T., HARDER, F., HEBERER, M. and SPAGNOLI, G.C., High expression of MAGE-3 protein in squamous-cell lung carcinoma. Int. J. Cancer. 71, 1119-1121 (1997).
7. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHÉ, B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
8. HAAS, G.G., JR., D'CRUZ, O.J. and DE BAULT, L.E., Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Amer. J. Reprod. Immunol. Microbiol., 18, 47-51 (1988).
9. HERMAN, J., VAN DER BRUGGEN, P., LUESCHER, I., MANDRUZZATO, S., ROMERO, P., THONNARD, J., FLEISCHHAUER, K., BOON, T. and COULIE, P.G., A peptide encoded by the human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics, 43, 377-383 (1996).
10. HOFBAUER, G.F.L., SCHAEFER, C., NOPPEN, C., BÖNI, R., KAMARASHEV, J., NESTLÉ, F.O., SPAGNOLI, G.C. and DUMMER, R., MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma. Frequency and distribution. Amer. J. Pathol., 151, 1549-1553 (1997).
11. KOCHER, T., SCHULTZ-THATER, E., GUDAT, F., SCHAEFER, C., CASORATI, G., JURETIC, A., WILLIMANN, T., HARDER, F., HEBERER, M. and SPAGNOLI, G.C., Identification and intracellular location of MAGE-3 gene product. Cancer Res., 55, 2236-2239 (1995).
12. LUCAS, S., BRASSEUR, F. and BOON, T., A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res., 59, 4100-4103 (1999).
13. LUCAS, S., DE SMET, C., ARDEN, K.C., VIARS, C.S., LETHÉ, B., LURQUIN, C. and BOON, T., Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res., 58, 743-752 (1998).
14. LURQUIN, C., DE SMET, C., BRASSEUR, F., MUSCATELLI, F., MARTELANGE, V., DE PLAEN, E., BRASSEUR, R., MONACO, A.P. and BOON, T., Two members of the human MAGE B gene family located in Xp.21.3 are expressed in tumors of various histological origins. Genomics, 46, 397-408 (1997).
15. MARCHAND, M. and 24 OTHERS, Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-Al. Int. J. Cancer, 80, 219-230 (1999).
16. MUSCATELLI, F., WALKER, A.P., DE PLAEN, E., STAFFORD, A.N. and MONACO, A.P., Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Nat. Acad. Sci. (Wash.), 92, 4987-4991 (1995).
17. POLD, M., ZHOU, J., CHEN, G.L., HALL, J.M., VESCIO, R.A. and BERENSON, J.R., Identification of a new, unorthodox member of the MAGE gene family. Genomics, 59, 161-167 (1999).
18. RAFF, T., VAN DER GIET, M., ENDEMANN, D., WIEDERHOLT, T. and PAUL, M., Design and testing of β-actin primers for RT-PCR that do not coamplify processed pseudogenes. Biotechniques, 23, 456-460 (1997).
19. RIMOLDI, D., SALVI, S. and SPAGNOLI, G.C., Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6Cl can be used to study different proteins of the MAGE-A family. Int. J. Cancer (2000), in press.
20. SERRANO, A., LETHÉ, B., DELROISSE, J.-M., LURQUIN, C., DE PLAEN, E., BRASSEUR, F., RIMOLDI, D. and BOON, T., Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries. Int. J. Cancer, 83, 664-669 (1999).
21. TAKAHASHI, K., SHICHUO, S., NOGUCHI, M., HIROHATA, M. and ITOH, K., Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res., 55, 3478-3482 (1995).
22. TANAKA, F., FUJIE, T., TAHARA, K., MORI, M., TAKESAKO, K., SETTE, A., CELIS, E. and AKIYOSHI, T., Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res., 57, 4465-4468 (1997).
23. VAN BAREN, N., BRASSEUR, F., GODELAINE, D., HAMES, G., FERRANT, A., LEHMANN, F., ANDRÉ, M., RAVOET, C., DOYEN, C., SPAGNOLI, G.C., BAKKUS, M., THELEMANS, K. and BOON, T., Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood, 94, 1156-1164 (1999).
24. VAN DEN EYNDE, B. and VAN DER BRUGGEN, P., T cell-defined tumor antigens. Curr. Opin. Immunol., 9, 684-693 (1997).
25. VAN DER BRUGGEN, P., BASTIN, J., GAJEWSKI, T., COULIE, P.C., BOËL, P., DE SMET, C., TRAVERSARI, C., TOWNSEND, A. and BOON, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Europ. J. Immunol., 24, 3038-3043 (1994).